A clinical trial in the U.K. is evaluating a new blood test that could reshape how Alzheimer’s disease is diagnosed, according to The National.
Participants showing early signs of dementia are being recruited through NHS memory clinics to evaluate the test’s effectiveness. Researchers expect to have conclusive results within the next three years.
The project, led by University College London, focuses on whether measuring levels of the protein p-tau217 in blood samples can lead to faster and more accurate detection of Alzheimer’s disease. Early studies indicate that the test can identify individuals with cognitive decline with about 80 percent...